BioNTech COVID-19 Variant Vaccine Study
COVID-19 Variant Vaccine Studies in Columbus
Centricity Research is currently participating in an investigational COVID-19 variant study at our Columbus, Ohio location. As new COVID-19 variants continue to evolve, clinical trials are a crucial part of advancing medical research to combat these evolving SARS-CoV-2 variant strains.
BioNTech SARS-CoV-2 multivalent RNA Vaccine Study
The primary objective of this clinical trial is to investigate the safety and effectiveness of several investigational new vaccines against new strains of the original SARS-CoV-2 virus for the prevention of COVID-19 in healthy adults.
We are specifically looking for healthy adult volunteers who:
- are 18 through 85 years of age
- have received two or three doses of the Pfizer or Moderna COVID-19 vaccine and also been diagnosed with COVID-19 in 2022
As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.
Ready to Volunteer?
Volunteer today to see if you qualify for the BioNTech SARS-CoV-2 multivalent RNA vaccine clinical research study. Qualified volunteers may be compensated for time and travel.